Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40015942
Localisation
Germany
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
10/08/2023
Statut
Classification
1.5°C
Année cible
2030
Boehringer Ingelheim commits to reduce absolute scope 1 and 2 GHG emissions 58.9% by 2030 from a 2019 base year.* Boehringer Ingelheim also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, fuel and energy related activities, upstream transportation and distribution and use of sold products 27.5% wihtin the same timeframe. *The target boundary includes biogenic land-related emissions and removals from bioenergy feedstocks.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
LEI
529900ZRSR0LJ3Q4DH04
Source : Science Based Targets initiative | Données publiques